10967/276 - QDB Compounds

QsarDB Repository

Zukic, S.; Ivanova, L.; Zusinaite, E.; Merits, A.; Maran, U. Discovery of a Novel Phthalazine-Based VEGFR-2 Inhibitor by Machine Learning Analysis of Diverse Chemical Space with Favorable Pharmacophores and Its Evaluation in Glioblastoma Cell Lines. Results in Chemistry, Under revision

Compound

ID:141
Name:Compound 141
Description:Original numeration in publication: 6h
Labels:Training_set, Phthalazines
CAS:
InChi Code:InChI=1S/C29H23N5O2/c1-36-24-17-11-20(12-18-24)19-30-34-29(35)22-13-15-23(16-14-22)31-28-26-10-6-5-9-25(26)27(32-33-28)21-7-3-2-4-8-21/h2-19H,1H3,(H,31,33)(H,34,35)/b30-19+

Properties

pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]

ValueSource or prediction
6.22

El-Adl, K.; Ibrahim, M. K.; Khedr, F. a. A., H. S.; Eissa, I. H. Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2022, 355, e2100278. https://doi.org/10.1002/ardp.202100278

6.38923

Eq1: VEGFR-2 inhibition (Data used to train model)